Not applicableLooking for participantsNCT07201376
What this trial is testing
Assessment of Skin Lesions Using a Tissue Oxygen Imager Based on Protoporphyrin IX (PPIX) Fluorescence. This is an Open-label, Non-randomized, Feasibility Study That Includes a One-time Application of an FDA Approved Medication Followed by Local Imaging for Benign Skin Growth and Lesions Clinically
Who this might be right for
Non-Melanoma Skin Cancer (NMSC)Benign Skin Growth
Dartmouth-Hitchcock Medical Center 125